Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 18, 2011 - Issue 3
180
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Structural dynamics of the ΔE22 (Osaka) familial Alzheimer’s disease-linked amyloid β-protein

&
Pages 98-107 | Received 14 Feb 2011, Accepted 08 Apr 2011, Published online: 13 Jun 2011

References

  • Prusiner SB. Shattuck lecture – neurodegenerative diseases and prions. N Engl J Med 2001;344:1516–1526.
  • Vinters HV, Wang ZZ, Secor DL. Brain parenchymal and microvascular amyloid in Alzheimer’s disease. Brain Pathol 1996;6:179–195.
  • Goedert M, Spillantini MG. A century of Alzheimer’s disease. Science 2006;314:777–781.
  • Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992;256:184–185.
  • Roychaudhuri R, Yang M, Hoshi MM, Teplow DB. Amyloid β-protein assembly and Alzheimer disease. J Biol Chem 2009;284:4749–4753.
  • Ono K, Condron MM, Teplow DB. Structure-neurotoxicity relationships of amyloid β-protein oligomers. Proc Natl Acad Sci U S A 2009;106:14745–14750.
  • Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J. Early onset familial Alzheimer’s disease: mutation frequency in 31 families. Neurology 2003;60:235–239.
  • Wakutani Y, Watanabe K, Adachi Y, Wada-Isoe K, Urakami K, Ninomiya H, Saido TC, Hashimoto T, Iwatsubo T, Nakashima K. Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2004;75:1039–1042.
  • Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin JJ, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet 1992;1:218–221.
  • Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyendijk W, Frangione B. Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124–1126.
  • VanBroeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, Vegter-Van der Vlis M, Roos RA. Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 1990;248:1120–1122.
  • Tagliavini F., Rossi G., Padovani A., Magoni M., Andora G., Sgarzi M., Bizzi A., Savioardo M., Carella F., Morbin M., Giaccone G., Bugiani O. A new βPP mutation related to hereditary cerebral haemorrhage. Alzheimer's Rep. 2(Suppl.), 1999;S28.
  • Kamino K, Orr HT, Payami H, Wijsman EM, Alonso ME, Pulst SM, Anderson L, O’dahl S, Nemens E, White JA, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 1992;51:998–1014.
  • Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, et al. The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Aβ protofibril formation. Nat Neurosci 2001;4:887–893.
  • Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697–705.
  • Selkoe DJ, Podlisny MB. Deciphering the genetic basis of Alzheimer’s disease. Annu Rev Genomics Hum Genet 2002;3:67–99.
  • Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology 2000;20:8–22.
  • Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, Takuma H, Kuwano R, Imagawa M, Ataka S, et al. A new amyloid β variant favoring oligomerization in Alzheimer’s-type dementia. Ann Neurol 2008;63:377–387.
  • Lazo ND, Grant MA, Condron MC, Rigby AC, Teplow DB. On the nucleation of amyloid β-protein monomer folding. Protein Sci 2005;14:1581–1596.
  • Grant MA, Lazo ND, Lomakin A, Condron MM, Arai H, Yamin G, Rigby AC, Teplow DB. Familial Alzheimer’s disease mutations alter the stability of the amyloid β-protein monomer folding nucleus. Proc Natl Acad Sci U S A 2007;104:16522–16527.
  • Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem 1997;272:22364–22372.
  • Fezoui Y, Hartley DM, Harper JD, Khurana R, Walsh DM, Condron MM, Selkoe DJ, Lansbury PTJr, Fink AL, Teplow DB. An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments. Amyloid 2000;7:166–178.
  • Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB. On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A 1996;93:1125–1129.
  • Andreu JM, Timasheff SN. The measurement of cooperative protein self-assembly by turbidity and other techniques. Methods Enzymol 1986;130:47–59.
  • O’Nuallain B, Shivaprasad S, Kheterpal I, Wetzel R. Thermodynamics of Aβ(1-40) amyloid fibril elongation. Biochemistry 2005;44:12709–12718.
  • Bitan G, Teplow DB. Rapid photochemical cross-linking – a new tool for studies of metastable, amyloidogenic protein assemblies. Acc Chem Res 2004;37:357–364.
  • Bitan G, Lomakin A, Teplow DB. Amyloid β-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem 2001;276:35176–35184.
  • Teplow DB. Preparation of amyloid β-protein for structural and functional studies. Methods Enzymol 2006;413:20–33.
  • Kentsis A, Sosnick TR. Trifluoroethanol promotes helix formation by destabilizing backbone exposure: desolvation rather than native hydrogen bonding defines the kinetic pathway of dimeric coiled coil folding. Biochemistry 1998;37:14613–14622.
  • Buck M. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q Rev Biophys 1998;31:297–355.
  • Barrow CJ, Yasuda A, Kenny PT, Zagorski MG. Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer’s disease. Analysis of circular dichroism spectra. J Mol Biol 1992;225:1075–1093.
  • Groenning M. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils – current status. J Chem Biol 2010;3:1–18.
  • LeVine H III. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 1999;309: 274–284.
  • Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A 2003;100:330–335.
  • Takuma H, Teraoka R, Mori H, Tomiyama T. Amyloid-β E22Δvariant induces synaptic alteration in mouse hippocampal slices. NeuroReport 2008;19:615–619.
  • Nishitsuji K, Tomiyama T, Ishibashi K, Ito K, Teraoka R, Lambert MP, Klein WL, Mori H. The E693Δ mutation in amyloid precursor protein increases intracellular accumulation of amyloid β oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells. Am J Pathol 2009;174:957–969.
  • Baumketner A, Bernstein SL, Wyttenbach T, Lazo ND, Teplow DB, Bowers MT, Shea JE. Structure of the 21-30 fragment of amyloid β-protein. Protein Sci 2006;15:1239–1247.
  • Peralvarez-Marin A, Mateos L, Zhang C, Singh S, Cedazo-Minguez A, Visa N, Morozova-Roche L, Gräslund A, Barth A. Influence of residue 22 on the folding, aggregation profile, and toxicity of the Alzheimer’s amyloid β peptide. Biophys J 2009;97:277–285.
  • Fawzi NL, Kohlstedt KL, Okabe Y, Head-Gordon T. Protofibril assemblies of the arctic, Dutch, and Flemish mutants of the Alzheimer’s Aβ1-40 peptide. Biophys J 2008;94:2007–2016.
  • Lam AR, Teplow DB, Stanley HE, Urbanc B. Effects of the Arctic (E22→G) mutation on amyloid β-protein folding: discrete molecular dynamics study. J Am Chem Soc 2008;130:17413–17422.
  • Melchor JP, McVoy L, Van Nostrand WE. Charge alterations of E22 enhance the pathogenic properties of the amyloid β-protein. J Neurochem 2000;74:2209–2212.
  • Maji SK, Amsden JJ, Rothschild KJ, Condron MM, Teplow DB. Conformational dynamics of amyloid β-protein assembly probed using intrinsic fluorescence. Biochemistry 2005;44: 13365–13376.
  • Maji SK, OgorzalekLoo RR, Inayathullah M, Spring SM, Vollers SS, Condron MM, Bitan G, Loo JA, Teplow DB. Amino acid position-specific contributions to amyloid β-protein oligomerization. J Biol Chem 2009;284:23580–23591.
  • Kirkitadze MD, Condron MM, Teplow DB. Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis. J Mol Biol 2001;312:1103–1119.
  • Yang M, Teplow DB. Amyloid β-protein monomer folding: free-energy surfaces reveal alloform-specific differences. J Mol Biol 2008;384:450–464.
  • Teplow DB, Lazo ND, Bitan G, Bernstein S, Wyttenbach T, Bowers MT, Baumketner A, Shea JE, Urbanc B, Cruz L, et al. Elucidating amyloid β-protein folding and assembly: a multidisciplinary approach. Acc Chem Res 2006;39:635–645.
  • Sgourakis NG, Yan Y, McCallum SA, Wang C, Garcia AE. The Alzheimer’s peptides Aβ40 and 42 adopt distinct conformations in water: a combined MD/NMR study. J Mol Biol 2007;368:1448–1457.
  • Fezoui Y, Teplow DB. Kinetic studies of amyloid β-protein fibril assembly. Differential effects of α-helix stabilization. J Biol Chem 2002;277:36948–36954.
  • Williams AD, Portelius E, Kheterpal I, Guo JT, Cook KD, Xu Y, Wetzel R. Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis. J Mol Biol 2004;335: 833–842.
  • Williams AD, Shivaprasad S, Wetzel R. Alanine scanning mutagenesis of Aβ(1-40) amyloid fibril stability. J Mol Biol 2006;357:1283–1294.
  • Kusumoto Y, Lomakin A, Teplow DB, Benedek GB. Temperature dependence of amyloid β-protein fibrillization. Proc Natl Acad Sci U S A 1998;95:12277–12282.
  • Esler WP, Stimson ER, Jennings JM, Vinters HV, Ghilardi JR, Lee JP, Mantyh PW, Maggio JE. Alzheimer’s disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 2000;39:6288–6295.
  • Massi F, Straub JE. Energy landscape theory for Alzheimer’s amyloid β-peptide fibril elongation. Proteins 2001;42:217–229.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.